M. R. Haverkate, T. N. Platteel, A. C. Fluit, J. W. Cohen Stuart, M. A

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors S. Amit, H. Mishali, T. Kotlovsky,

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

Defining an extended-spectrum β-lactamase

I.J. Schalk Clinical Microbiology and Infection

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Herpes zoster in non-hospitalized children

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Evolution of extended-spectrum β-lactamases by mutation

Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain Y.

Defining an extended-spectrum β-lactamase

J.-P. Van geertruyden Clinical Microbiology and Infection

Refugee crisis and re-emergence of forgotten infections in Europe

R. Cantón Clinical Microbiology and Infection

A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin

A.E. Muller, U. Theuretzbacher, J.W. Mouton

Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? J.-Y. Madec, M. Haenni, P. Nordmann,

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Dermatitis by Dermatophilus congolensis

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 V.

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum.

Vector control: a cornerstone in the malaria elimination campaign

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses W.G. Melsen, M.C.J. Bootsma, M.M. Rovers,

Predictors for individual patient antibiotic treatment effect in hospitalized community- acquired pneumonia patients A.F. Simonetti, C.H. van Werkhoven,

Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients.

Prevalence of extended-spectrum β-lactamases in isolates of the Enterobacter cloacae complex from German hospitals H. Hoffmann, E. Stürenburg, J. Heesemann,

Isospora belli Clinical Microbiology and Infection

B. Gordts Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

C. Varela, A. Oliver, T.M. Coque, F. Baquero, R. Canton

Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus (ST398) in Dutch hospitals M.W.M. Wassenberg, M.C.J. Bootsma, A.

Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital L. Gibold, F. Robin, R.-N.

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

Previously unknown species of Aspergillus

Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study M.

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Abstracts cont. Clinical Microbiology and Infection

Cessation of screening for intestinal carriage of extended-spectrum β-lactamase- producing Enterobacteriaceae in a low-endemicity intensive care unit with.

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain L. Vinué, Y. Sáenz, S. Martínez,

S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K

Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit S. Nseir, C. Blazejewski, R. Lubret,

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

New oral cephalosporins in pediatric community-acquired infections

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Multi-centre evaluation of a phenotypic extended spectrum β-lactamase detection guideline in the routine setting T.N. Platteel, J.W. Cohen Stuart, A.J.

Presentation transcript:

Quantifying within-household transmission of extended-spectrum β-lactamase- producing bacteria M.R. Haverkate, T.N. Platteel, A.C. Fluit, J.W. Cohen Stuart, M.A. Leverstein-van Hall, S.F.T. Thijsen, J. Scharringa, R.C. Kloosterman, M.J.M. Bonten, M.C.J. Bootsma Clinical Microbiology and Infection Volume 23, Issue 1, Pages 46.e1-46.e7 (January 2017) DOI: 10.1016/j.cmi.2016.08.021 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Prevalence and relative contributions of hospital acquisition, travel acquisition, within-household transmission, and between-household transmission to the prevalence of extended-spectrum β-lactamase (ESBL). B/W, between-household transmission rate defined as a fraction of the within-household transmission rate. The coloured areas indicate the relative contributions of the different ESBL sources on the modelled prevalence. ‘Unknown’ indicates the contribution of the hypothetical external source to reach a prevalence of 4%. Clinical Microbiology and Infection 2017 23, 46.e1-46.e7DOI: (10.1016/j.cmi.2016.08.021) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions